Mirae Asset Global ETFs Holdings’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
290,087
-45,321
-14% -$154K ﹤0.01% 1404
2026
Q1
$590K Sell
335,408
-55,651
-14% -$121K ﹤0.01% 1801
2025
Q4
$919K Buy
391,059
+1,224
+0.3% +$3.35K ﹤0.01% 1568
2025
Q3
$1.19M Sell
389,835
-3,287
-0.8% -$9.39K ﹤0.01% 1384
2025
Q2
$1.1M Buy
+393,122
New +$1.29M ﹤0.01% 1401

Other funds holding CLOV

Mirae Asset Global ETFs Holdings's CLOV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Clover Health Investments (CLOV) stake by 14% in Q2 2026, selling an estimated $154K and leaving 290,087 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Mirae Asset Global ETFs Holdings first reported a position in CLOV in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 290,087 shares of Clover Health Investments worth $1.52M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 45,321 Clover Health Investments shares in Q2 2026, an estimated $154K.
  • Clover Health Investments made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1404 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Clover Health Investments in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.